When a loved one with Parkinson's starts seeing people who aren't there, the safest response is to tell the care team, not to keep it quiet. Hallucinations and delusions are a recognized, treatable part of the disease, and hiding them mainly delays the help that could ease them.
Parkinson's disease psychosis (PDP) means hallucinations (seeing, hearing, or sensing things that aren't real) or delusions (fixed false beliefs) caused by the disease and its treatment. It is common: the Parkinson's Foundation reports it affects up to 75% of patients over the course of the illness. Silence is understandable, but this article explains why it backfires and what to do instead.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why so many families keep it a secret
- How common is this, really?
- The risk that makes silence the wrong bet
- What happens after you report it
- The limits and warnings worth knowing
- Frequently Asked Questions
Why so many families keep it a secret
The impulse to hide hallucinations is widespread, and it comes from both sides of the caregiving relationship. A clinical review published in PMC found patients often stay quiet for fear of being thought "crazy," while caregivers stay quiet out of embarrassment. Underlying both is a sharper fear: that reporting symptoms will trigger hospitalization or a move to a care home. That concealment has a cost.
Because patients, families, and clinicians all under-report, PDP is widely underrecognized and undertreated, according to touchNEUROLOGY. Some families simply don't connect the hallucinations to Parkinson's at all, so they never think to mention them. The result is a quiet problem that stays quiet until a crisis forces it into the open. By then, options that work best early may have narrowed.
How common is this, really?
Hallucinations in Parkinson's are the rule over time, not the exception. More than half of people with the disease develop psychosis at some point, which the journal AJMC describes as a common complication rather than a rare event. At any given moment, roughly 20–40% report hallucinations or delusions.
The symptoms sit on a spectrum. The most common are visual, and the mildest forms are easy to dismiss: A PMC review notes these minor forms can appear even before the movement symptoms Parkinson's is known for. Knowing the mild end of the range helps families name what they're seeing instead of explaining it away.
- Presence hallucinations — a sense that someone is nearby when no one is there
- Passage hallucinations — a fleeting figure or animal glimpsed at the edge of vision
- Full visual hallucinations — clearly seeing people, animals, or objects that aren't present
- Delusions — fixed false beliefs, such as a spouse being unfaithful or caregivers stealing
The risk that makes silence the wrong bet
The fear driving concealment — losing the person to a care home — is exactly what concealment makes more likely. A study in the Journal of the American Geriatrics Society found hallucinations and delusions are independent predictors of nursing-home placement, ranking among the strongest predictors of institutionalization in Parkinson's. Read that carefully: untreated psychosis pushes toward placement. Reporting it early opens the door to treatment that can reduce the symptoms and the caregiver strain they create.
The secret protects the outcome the family dreads most. There is also insight to consider. Early on, many people know their hallucinations aren't real and feel little distress, so calm reassurance may be enough, per a PMC review of psychosis management. Insight is often lost as the disease progresses — another reason to raise it while the person can still take part in the conversation.
📨 Get Free Parkinson's Guides Alerts
Free · No spam · Unsubscribe anytime
What happens after you report it
Telling the care team does not mean an immediate move to strong drugs. The first step is screening, education, and a medication review, because hallucinations can be triggered by a change in dopaminergic (dopamine-boosting) Parkinson's medication or by an unrelated problem like a urinary or chest infection.
The Parkinson's Foundation lists this review as the starting point precisely because a reversible cause may be found. Practical steps for a caregiver preparing that conversation: Only after this does drug treatment come into focus. Pimavanserin (brand name NUPLAZID) was approved by the FDA on April 29, 2016 as the first drug specifically for Parkinson's psychosis, according to the ACADIA approval release; it targets serotonin rather than dopamine, so it does not worsen movement symptoms the way older antipsychotics do.
- Write down what was seen or believed, when it happened, and how often
- Note any recent medication change or new dose, and any signs of infection
- Record whether the person knew the hallucination wasn't real
- Bring the list to the neurologist or Parkinson's nurse rather than waiting for a scheduled review
The limits and warnings worth knowing
Treatment is not risk-free, which is another reason it belongs with a clinician rather than a family debate. Pimavanserin and older antipsychotics carry a boxed warning for increased death in elderly people with dementia-related psychosis, and conventional antipsychotics can worsen Parkinson's motor symptoms, as summarized by StatPearls via NIH. That is exactly why medication review comes before any new antipsychotic, and why self-medicating or borrowing pills is dangerous.
The takeaway is not that treatment is scary, but that it requires a professional weighing benefit against risk for one specific person. A family cannot make that call from behind closed doors. Bring the symptom to the people equipped to manage it, early, while insight and options are both still available.
Frequently Asked Questions
Should I contradict my loved one during a hallucination?
If they retain insight and aren't distressed, calm reassurance often suffices. Arguing with a fixed delusion rarely helps; note it and report it to the care team instead.
Could a new medication be causing the hallucinations?
Yes. A change in dopaminergic Parkinson's medication is a recognized trigger, which is why a medication review is the first step before adding any new drug.
Are hallucinations a sign the disease is near the end?
Not necessarily. Minor hallucinations can appear early, sometimes before movement symptoms, and are common across the disease course rather than only in late stages.
You Might Also Like
- When a Parkinson’s Care Partner Needs to Repeat Instructions Without Raising Their Voice
- What Is New With Caregiver Support for Parkinson’s Disease in August 2026? Latest NIH, FDA, and trial records and Key Takeaways
- Parkinson’s Caregivers and the Hidden Work of Prompting Every Step